Nuzenio

Phase Ii Study

Phase Ii Study news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMTInhaled IPF therapy moves to Phase 2 as early trial shows promise - Pulmonary Fibrosis NewsPulmonary Fibrosis News · Wed, 05 Aug 2026 19:06:08 GMTSanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 18:50:22 GMTSanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 12:02:58 GMTRocket points to Danon gene therapy’s safety after Phase II protocol change - yahoo.comyahoo.com · Tue, 04 Aug 2026 11:03:42 GMTMerck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 10:30:00 GMT

Timeline

Mon, 10 Aug 2026 04:31:46 GMTAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila Times
Fri, 07 Aug 2026 23:10:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLive
Thu, 06 Aug 2026 16:25:44 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSci
Wed, 05 Aug 2026 19:06:08 GMTInhaled IPF therapy moves to Phase 2 as early trial shows promise - Pulmonary Fibrosis News
Wed, 05 Aug 2026 18:50:22 GMTSanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ - Fierce Biotech
Wed, 05 Aug 2026 12:02:58 GMTSanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phase Ii Study.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.